Continued Semaglutide 2.4 mg Once Weekly Improved Health Related Quality of Life in the STEP 4 Trial

被引：0
|
作者：
Sharma, Arya
Meincke, Henrik
Jensen, Camilla
Kushner, Robert
Pedersen, Sue
Rubino, Domenica
Tran, Marie
Wharton, Sean
Bjorner, Jakob
机构：
来源：
OBESITY | 2021年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
014
引用
收藏
页码：9 / 10
页数：2
相关论文
共 50 条
  • [41] Treatment with Once-Weekly Semaglutide 2.4 mg Improves Cardiometabolic Risk Factors in Adults with Overweight/Obesity and Type 2 Diabetes: STEP 2 Post-hoc Analysis
    Kushner, Robert F.
    Davies, Melanie J.
    Deanfield, John
    Garvey, W. Timothy
    Jeppesen, Ole
    Khalid, Usman
    Kosiborod, Mikhail N.
    Laursen, Peter N.
    Rubino, Domenica
    Verma, Subodh
    DIABETES, 2021, 70
  • [42] Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg in adults with overweight or obesity, and the relationship between gastrointestinal adverse events and weight loss
    Wharton, Sean
    Calanna, Salvatore
    Davies, Melanie
    Dicker, Dror
    Goldman, Bryan
    Lingvay, Ildiko
    Mosenzon, Ofri
    Rubino, Domenica M.
    Thomsen, Mette
    Wadden, Thomas A.
    Pedersen, Sue D.
    DIABETES OBESITY & METABOLISM, 2022, 24 (01): : 94 - 105
  • [43] Effect of semaglutide 2.4 mg on alanine aminotransferase in adolescents with obesity: a post-hoc analysis of the STEP TEENS trial
    Weghuber, Daniel
    Gies, Inge
    Gluud, Lise Lotte
    Iversen, Aske Thorn
    Jara, Maximilian
    Schmidt, Signe
    Sorrig, Rasmus
    Wabitsch, Martin
    Noureddin, Mazen
    JOURNAL OF HEPATOLOGY, 2023, 78 : S71 - S71
  • [44] Improved diabetes treatment satisfaction and weight-related quality of life with both exenatide once weekly and twice daily
    Kim, Terrih.
    Boye, Kristinas.
    Wintle, Matthew
    Hufford, Michael R.
    Rubin, Richard R.
    DIABETES, 2008, 57 : A147 - A148
  • [45] Semaglutide 2.4 mg improved glucose metabolism and reverted prediabetes to normoglycaemia in adults with overweight or obesity vs liraglutide 3.0 mg (STEP 8)
    Idris, Iskandar
    Rubino, Domenica
    Garvey, W. Timothy
    Goldman, Bryan
    Khalid, Usman
    Rosenstock, Julio
    Sorrig, Rasmus
    OBESITY SURGERY, 2023, 33 : S39 - S39
  • [46] Semaglutide 2.4 mg improved glucose metabolism and reverted prediabetes to normoglycaemia in adults with overweight or obesity vs liraglutide 3.0 mg (STEP 8)
    Rubino, D. M.
    Garvey, T. W.
    Goldman, B.
    Khalid, U.
    Rosenstock, J.
    Sorrig, R.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S287 - S288
  • [47] Effect of semaglutide 2.4 mg on physical functioning and weight- and health-related quality of life in adults with overweight or obesity: Patient-reported outcomes from the STEP 1-4 trials (vol 26, pg 2945, 2024)
    Rubino, D.
    Bjorner, J. B.
    Rathor, N.
    Sharma, A. M.
    Smith, L. von Huth
    Wharton, S.
    Wadden, T.
    Zeuthen, N.
    Kolotkin, R. L.
    DIABETES OBESITY & METABOLISM, 2025, 27 (03): : 1631 - 1631
  • [48] Semaglutide-Induced Weight Loss Is Associated with Improved Health-Related Quality of Life and Treatment Satisfaction
    Uusinarkaus, Kari T.
    Rodbard, Helena W.
    Van Gaal, Luc
    Wilding, John P.
    Hansen, Thomas
    Sandberg, Anna
    Tadayon, Sayeh
    Davies, Melanie J.
    DIABETES, 2019, 68
  • [49] Semaglutide 2.4 mg efficacy and safety in people with obesity and knee osteoarthritis: Results: from the STEP 9 randomised clinical trial
    Bliddal, Henning
    Bays, Harold
    Czernichow, Sebastien
    Hemmingsson, Joanna U.
    Hjelmesaeth, Joran
    Morville, Thomas H.
    Koroleva, Anna
    Neergaard, Jesper S.
    Wharton, Sean
    Wizert, Alicja
    Kristensen, Lars Erik
    OSTEOARTHRITIS AND CARTILAGE, 2024, 32 (06) : 745 - 746
  • [50] Semaglutide 2.4 mg Improved Glucose Metabolism and Reverted Prediabetes to Normoglycemia in Adults with Overweight/Obesity vs. Liraglutide 3.0 mg (STEP 8)
    Rosenstock, Julio
    Garvey, W. Timothy
    Goldman, Bryan
    Khalid, Usman
    Sorrig, Rasmus
    Rubino, Domenica
    DIABETES, 2022, 71
12345